Evoke Pharma Inc (EVOK) insider trading
Every open-market stock purchase and sale by Evoke Pharma Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $95.9K over the last 12 months (1 sale). No open-market buys.
- Last insider buy: Lvp GP III LLC (10% owner), $1.1M, 8 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $95.9K (1 sale). Last close $11.00 on Dec 15, 2025.
Recent EVOK insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Dec 17, 2025 | Nantahala Capital Management LLC (10% owner) | Sold (not open market) | $4.8M |
| Dec 17, 2025 | Nantahala Capital Management LLC (10% owner) | Sold (not open market) | $2.8M |
| Dec 17, 2025 | Nantahala Capital Management LLC (10% owner) | Sold (not open market) | $1.7M |
| Dec 17, 2025 | Nantahala Capital Management LLC (10% owner) | Sold (not open market) | $1.6M |
| Dec 17, 2025 | Nantahala Capital Management LLC (10% owner) | Sold (not open market) | $551K |
| Dec 17, 2025 | Matthew J D'Onofrio (CEO) | Sold (not open market) | $342K |
| Dec 17, 2025 | Matthew J D'Onofrio (CEO) | Sold (not open market) | $312K |
| Dec 17, 2025 | Marilyn R. Carlson (C-suite exec) | Sold (not open market) | $91.1K |
| Dec 17, 2025 | Mark Kowieski (CFO) | Sold (not open market) | $91.1K |
| Dec 17, 2025 | Mark Kowieski (CFO) | Sold (not open market) | $57.9K |
| Dec 17, 2025 | Marilyn R. Carlson (C-suite exec) | Sold (not open market) | $49K |
| Dec 17, 2025 | Cam L Garner (Insider) | Sold (not open market) | $38.9K |
| Dec 17, 2025 | Benjamin C. Smeal (Insider) | Sold (not open market) | $32.1K |
| Dec 17, 2025 | Greg Pyszczymuka (Insider) | Sold (not open market) | $30.7K |
| Dec 17, 2025 | Malcolm R Hill (Insider) | Sold (not open market) | $26K |
| Dec 17, 2025 | Vickie S Reed (Insider) | Sold (not open market) | $26K |
| Dec 17, 2025 | Kenneth J Widder (Insider) | Sold (not open market) | $26K |
| Dec 17, 2025 | Todd C Brady (Insider) | Sold (not open market) | $26K |
| Dec 17, 2025 | Cam L Garner (Insider) | Sold (not open market) | $8K |
| Dec 17, 2025 | Todd C Brady (Insider) | Sold (not open market) | $6.6K |
| Dec 17, 2025 | Cam L Garner (Insider) | Sold (not open market) | $4.5K |
| Dec 17, 2025 | Vickie S Reed (Insider) | Sold (not open market) | $4.3K |
| Dec 17, 2025 | Malcolm R Hill (Insider) | Sold (not open market) | $4.2K |
| Dec 17, 2025 | Kenneth J Widder (Insider) | Sold (not open market) | $4.1K |
| Dec 17, 2025 | Todd C Brady (Insider) | Sold (not open market) | $4.1K |
Who's trading EVOK
- Kenneth J Widder, Insider: other filings, last Dec 17, 2025
- Marilyn R. Carlson, C-suite exec: other filings, last Dec 17, 2025
- Matthew J D'Onofrio, CEO: other filings, last Dec 17, 2025
- Cam L Garner, Insider: other filings, last Dec 17, 2025
- Malcolm R Hill, Insider: other filings, last Dec 17, 2025
- Todd C Brady, Insider: other filings, last Dec 17, 2025
- Mark Kowieski, CFO: other filings, last Dec 17, 2025
- Nantahala Capital Management LLC, 10% owner: other filings, last Dec 17, 2025
- Greg Pyszczymuka, Insider: other filings, last Dec 17, 2025
- Vickie S Reed, Insider: other filings, last Dec 17, 2025
- Benjamin C. Smeal, Insider: other filings, last Dec 17, 2025
- Roger M. Klein, 10% owner: sold $95.9K (2 sales), last Nov 6, 2025
Get free alerts when an insider at Evoke Pharma Inc files a new trade →